Who owns the FA15 trademark?

The FA15 trademark is owned by Seraphina Therapeutics, Inc..

What class is the FA15 trademark registered in?

The FA15 trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for FA15?

The USPTO serial number for FA15 is 88942226.

What is the registration number for FA15?

FA15 is registered under USPTO registration number 6390917.

Sealvo

Home Search: FA15FA15 #88942226

Back

Updated Oct 26, 2026·40 searches this week

View on USPTO TSDR Find similar marks

FA1

USPTO Trademark Record

REGISTERED

FA15

SN 88942226·Reg 6390917·Filed Jun 01, 2020

Owner Seraphina Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

FA15 (Serial No. 88942226), Registration No. 6390917, is a registered US trademark filed on Jun 01, 2020 by Seraphina Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Renewal window: June 15, 2027232 days remaining

Mark Intelligence

FA15 (Reg. #6390917) is a registered US trademark that has been protecting its owner, Seraphina Therapeutics, Inc., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jun 01, 2020

SERIAL

88942226

REG#

6390917

REGISTERED

Jun 15, 2021

Filing Information

StatusREGISTERED

Filing DateJun 01, 2020

Serial Number88942226

Registration No.6390917

Registration DateJun 15, 2021

Status DateJun 15, 2021

Published for OppositionAug 25, 2020

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

International Filings

Madrid Protocol1 filings

This mark has 1 Madrid Protocol filing on record with the USPTO.

1740966

480Jun 26, 2023

Source: USPTO Madrid International Filing Requests

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Oct 01, 2020

First use in commerce: Oct 01, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

47 events

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Jun 15, 2026

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

Feb 20, 2024

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED

CORRECTION UNDER SECTION 7 - PROCESSED

Jan 17, 2024

CORRECTION UNDER SECTION 7 - PROCESSED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jan 16, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

TEAS SECTION 7 REQUEST RECEIVED

May 09, 2023

TEAS SECTION 7 REQUEST RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

May 08, 2023

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

May 08, 2023

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 08, 2023

TEAS CHANGE OF CORRESPONDENCE RECEIVED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jul 01, 2021

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 01, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jul 01, 2021

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

REGISTERED-PRINCIPAL REGISTER

Jun 15, 2021

REGISTERED-PRINCIPAL REGISTER

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 11, 2021

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ASSIGNED TO LIE

May 10, 2021

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 10, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 10, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 10, 2021

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

TEAS REQUEST FOR RECONSIDERATION RECEIVED

May 05, 2021

TEAS REQUEST FOR RECONSIDERATION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 25, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 25, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

SU - FINAL REFUSAL - WRITTEN

Mar 25, 2021

SU - FINAL REFUSAL - WRITTEN

FINAL REFUSAL E-MAILED

Mar 25, 2021

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 25, 2021

NOTIFICATION OF FINAL REFUSAL EMAILED

ASSIGNED TO LIE

Mar 24, 2021

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 22, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Mar 10, 2021

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Mar 10, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 10, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 18, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 18, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Feb 17, 2021

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 15, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Nov 14, 2020

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Nov 14, 2020

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Nov 14, 2020

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 13, 2020

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Nov 13, 2020

STATEMENT OF USE PROCESSING COMPLETE

USE AMENDMENT FILED

Nov 01, 2020

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Nov 01, 2020

TEAS STATEMENT OF USE RECEIVED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 20, 2020

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 25, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 25, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 05, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 21, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Jul 13, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 22, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 04, 2020

NEW APPLICATION ENTERED

Other Marks by Seraphina Therapeutics, Inc.

Additional USPTO filings from the same owner.

FAT

FATTY15

88835166

Seraphina Therapeutics, Inc.

REGISTERED

NER

NERDY DO-GOODER

99023365

Seraphina Therapeutics, Inc.

REGISTERED

AGE

AGE WELL, CELL BY CELL

50149236

Seraphina Therapeutics, Inc.

PENDING

LON

LONG LIVE US.

50060212

Seraphina Therapeutics, Inc.

PENDING

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

FA1

FA15

97088301

Seraphina Therapeutics

ABANDONED

FA1

FA15

90469506

Seraphina Therapeutics

ABANDONED

Other Marks by Ian W. Gillies

Additional USPTO filings handled by the same attorney of record.

THE

THE LODGE TORREY PINES

75769549

REGISTERED

CLI

CLICS

87069823

REGISTERED

THE

THE RESCUER

99749568

REGISTERED

STO

STORY OF THIS LIFE

99749580

REGISTERED

FA15

Run a conflict check

Other Marks by Seraphina Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Ian W. Gillies

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company